Skip to main content
. 2021 Jun 9;8:679171. doi: 10.3389/fmed.2021.679171

Table 2.

Clinical characteristics and biochemistries in patients with Gitelman syndrome.

Patients 1 2 3 4 5 6 7 8 9 10 Mean ± SD
SBP/DBP (mmHg) 123/65 111/68 120/80 114/78 128/70 120/64 126/64 120/70 105/84 115/68 116.2 ± 7.5/69.7 ± 7.4
Serum Reference
BUN (mmol/L) 2.50–8.93 5.71 5.36 7.85 4.64 6.07 5.36 7.14 4.64 4.28 5.71 5.68 ± 1.12
Creatinine (μmol/L) 61.9–106.1 79.6 88.4 114.9 53 0 106.1 106.1 88.4 97.2 70.7 97.2 90.17.0 ± 18.54
Sodium (mmol/L) 136–145 135 135 138 132 140 142 138 137 134 134 137.1 ± 3.1
Potassium (mmol/L) 3.5–5.1 2.6 1.9 2.4 2.9 2.8 2.3 2.1 2.1 1.5 2.8 2.34 ± 0.45
Chloride (mmol/L) 98–107 97 100 98 94 97 99 97 98 96 96 97.2 ± 1.7
Total Calcium (mmol/L) 2.15–2.55 2.33 2.20 2.33 2.35 2.53 2.45 2.50 2.23 2.45 2.45 2.38 ± 0.11
Magnesium (mmol/L) 0.7–1.05 0.53 0.66 0.62 0.62 0.70 0.66 0.74 0.58 0.62 0.53 0.63 ± 0.67
Hematocrit (%) 38.0–47.0 45.7 49.0 46.3 39.9 53.9 54.0 48.3 46.8 44.4 45.6 47.4 ± 4.3
Albumin (g/L) 35–57 43 37 43 48 47 46 43 38 46 45 44 ± 4
PRA (ng/ml/hr) 1.31–3.95 17.15 10.29 47.13 6.32 50.00 31.97 38.35 29.04 30.35 29.14 28.9 ± 14.4
PAC (pg/ml) 70–350 252 206 140 147 134 266 304 320 288 237 229.4 ± 69.6
HCO3 (mmol/L) 24 31.6 27.2 30.7 28.0 33.0 26.8 28.0 22.6 24.1 35.1 28.7 ± 3.9
Urine
Creatinine (mmol/L) 10.6 9.4 7.9 5.7 7.3 2.1 7.9 6.2 4.7 5.2 8.6 ± 3.8
Sodium (mmol/L) 172 53 58 66 64 46 96 32 42 199 82.8 ± 57.1
Potassium (mmol/L) 45 21 27 48 43 26 17 56 37 49 36.9 ± 13.3
Chloride (mmol/L) 143 86 93 67 44 59 51 35 77 207 86.2 ± 52.4
Calcium (mmol/L) 0.58 0.55 0.25 1.28 0.23 0.05 0.10 0.63 0.38 0.53 0.46 ± 0.35
Magnesium (mmol/L) 3.09 2.55 2.34 3.58 3.17 0.86 0.62 2.26 1.52 4.61 2.46 ± 1.23
TTKG 7.15 7.28 7.10 10.80 12.51 12.61 7.13 41.13 22.67 6.23 13.46 ± 10.91

SBP, systolic blood pressure; DBP, diastolic blood pressure; PRA, plasma renin activity; PAC, plasma aldosterone concentration; TTKG, transtubular potassium gradient.